Evidence map›Paper›PMID 20868739›Full record

ArticleBrain, behavior, and immunity2011

CNS-derived CCL21 is both sufficient to drive homeostatic CD4+ T cell proliferation and necessary for efficient CD4+ T cell migration into the CNS parenchyma following Toxoplasma gondii infection.

Corinne C Ploix, Shahani Noor, Janelle Crane, Kokoechat Masek, Whitney Carter, David D Lo, Emma H Wilson, Monica J Carson

Open access · greenAbstract read
In one paragraph

Article in Brain, behavior, and immunity, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. From the immune system to mood disorders especially induced byFrontiers in cellular and infection microbiology · 2023
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Drainage of cells and soluble antigen from the CNS to regional lymph nodes.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Corinne C PloixRoche Ltd., Basel, Switzerland.
Shahani Noor
Janelle Crane
Kokoechat Masek
Whitney Carter
David D Lo
Emma H Wilson
Monica J Carson
University of California, Riverside · USRoche (Switzerland) · CH

Funding

Genes regulating M cell differentiationR01AI063426 · NIAID · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI LO, DAVID D · 2005 to 2016
$3.6M
Triggering Receptors and CNS InflammationR01NS045735 · NINDS · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI CARSON, MONICA J · 2003 to 2006
$1.3M
M cell induction and function in mucosal tissuesR56AI063426 · NIAID · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI LO, DAVID D · 2017 to 2017
$291k
NIAID NIH HHS AI63426NIAID NIH HHS R01 AI063426NIAID NIH HHS R56 AI063426NINDS NIH HHS NS045735NINDS NIH HHS R01 NS045735
6 · The paper itself

Abstract

Injury, infection and autoimmune triggers increase CNS expression of the chemokine CCL21. Outside the CNS, CCL21 contributes to chronic inflammatory disease and autoimmunity by three mechanisms: recruitment of lymphocytes into injured or infected tissues, organization of inflammatory infiltrates into lymphoid-like structures and promotion of homeostatic CD4+ T-cell proliferation. To test if CCL21 plays the same role in CNS inflammation, we generated transgenic mice with astrocyte-driven expression of CCL21 (GFAP-CCL21 mice). Astrocyte-produced CCL21 was bioavailable and sufficient to support homeostatic CD4+ T-cell proliferation in cervical lymph nodes even in the absence of endogenous CCL19/CCL21. However, lymphocytes and glial-activation were not detected in the brains of uninfected GFAP-CCL21 mice, although CCL21 levels in GFAP-CCL21 brains were higher than levels expressed in inflamed Toxoplasma-infected non-transgenic brains. Following Toxoplasma infection, T-cell extravasation into submeningeal, perivascular and ventricular sites of infected CNS was not CCL21-dependent, occurring even in CCL19/CCL21-deficient mice. However, migration of extravasated CD4+, but not CD8+ T cells from extra-parenchymal CNS sites into the CNS parenchyma was CCL21-dependent. CD4+ T cells preferentially accumulated at perivascular, submeningeal and ventricular spaces in infected CCL21/CCL19-deficient mice. By contrast, greater numbers of CD4+ T cells infiltrated the parenchyma of infected GFAP-CCL21 mice than in wild-type or CCL19/CCL21-deficient mice. Together these data indicate that CCL21 expression within the CNS has the potential to contribute to T cell-mediated CNS pathology via: (a) homeostatic priming of CD4+ T-lymphocytes outside the CNS and (b) by facilitating CD4+ T-cell migration into parenchymal sites following pathogenic insults to the CNS.

Indexed as

AnimalsAstrocytesBlotting, NorthernBrainCD4-Positive T-LymphocytesChemokine CCL21Chemotaxis, LeukocyteIn Situ HybridizationLymphocyte ActivationMiceMice, TransgenicMicrogliaReverse Transcriptase Polymerase Chain ReactionToxoplasmaToxoplasmosis, CerebralChemokine CCL21

Identifiers

PMID20868739
PMCPMC3032828
OpenAlexW1968830168

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.